Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Cerebrospinal fluid and urinary biomarkers in multiple sclerosis.

Dobson R, Topping J, Davis A, Thompson E, Giovannoni G.

Acta Neurol Scand. 2013 Nov;128(5):321-7. doi: 10.1111/ane.12119. Epub 2013 Mar 7.

PMID:
23465040
2.

Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.

Kaplan B, Golderman S, Yahalom G, Yeskaraev R, Ziv T, Aizenbud BM, Sela BA, Livneh A.

J Immunol Methods. 2013 Apr 30;390(1-2):74-80. doi: 10.1016/j.jim.2013.01.010. Epub 2013 Jan 31.

PMID:
23376556
3.

Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.

Makshakov G, Nazarov V, Kochetova O, Surkova E, Lapin S, Evdoshenko E.

PLoS One. 2015 Nov 25;10(11):e0143375. doi: 10.1371/journal.pone.0143375. eCollection 2015.

4.

Free light chain monomers in the diagnosis of multiple sclerosis.

Kaplan B, Aizenbud BM, Golderman S, Yaskariev R, Sela BA.

J Neuroimmunol. 2010 Dec 15;229(1-2):263-71. doi: 10.1016/j.jneuroim.2010.09.002. Epub 2010 Sep 25.

PMID:
20870296
5.

Free light chains in the CSF in multiple sclerosis.

Bracco F, Gallo P, Menna R, Battistin L, Tavolato B.

J Neurol. 1987 Jun;234(5):303-7.

PMID:
3112315
6.

High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.

Hassan-Smith G, Durant L, Tsentemeidou A, Assi LK, Faint JM, Kalra S, Douglas MR, Curnow SJ.

J Neuroimmunol. 2014 Nov 15;276(1-2):175-9. doi: 10.1016/j.jneuroim.2014.08.003. Epub 2014 Aug 8.

PMID:
25146968
7.

Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.

Duranti F, Pieri M, Centonze D, Buttari F, Bernardini S, Dessi M.

J Neuroimmunol. 2013 Oct 15;263(1-2):116-20. doi: 10.1016/j.jneuroim.2013.07.006. Epub 2013 Aug 1.

PMID:
23916392
8.

Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.

Lourenco P, Shirani A, Saeedi J, Oger J, Schreiber WE, Tremlett H.

Mult Scler. 2013 Apr;19(5):577-84. doi: 10.1177/1352458512459684. Epub 2012 Sep 7.

PMID:
22961214
9.

Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis.

Krakauer M, Schaldemose Nielsen H, Jensen J, Sellebjerg F.

Acta Neurol Scand. 1998 Sep;98(3):161-5.

PMID:
9786611
10.

Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.

Stich O, Kluge J, Speck J, Rauer S.

Acta Neurol Scand. 2015 Jun;131(6):381-8. doi: 10.1111/ane.12350. Epub 2014 Nov 17.

PMID:
25402869
11.

Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry.

Desplat-Jégo S, Feuillet L, Pelletier J, Bernard D, Chérif AA, Boucraut J.

J Clin Immunol. 2005 Jul;25(4):338-45.

PMID:
16133990
12.

Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis.

Andreadou E, Chatzipanagiotou S, Constantinides VC, Rombos A, Stamboulis E, Nicolaou C.

Clin Neurol Neurosurg. 2013 Oct;115(10):2094-8. doi: 10.1016/j.clineuro.2013.07.026. Epub 2013 Aug 13.

PMID:
23953642
13.

Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis.

Goffette S, Schluep M, Henry H, Duprez T, Sindic CJ.

J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):308-10.

14.

Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.

Dobson R, Miller RF, Palmer HE, Feldmann M, Thompson EJ, Thompson AJ, Miller DH, Giovannoni G.

J Neuroimmunol. 2010 Mar 30;220(1-2):99-103. doi: 10.1016/j.jneuroim.2010.01.012. Epub 2010 Feb 19.

PMID:
20171744
15.

MR peri-CSF lesions and CSF oligoclonal bands in Italian multiple sclerosis patients.

Pichiecchio A, Tavazzi E, Maccabelli G, Ponzio M, Romani A, Schiappacassa R, Poloni GU, Franciotta D, Roccatagliata L, Bergamaschi R, Bastianello S.

Acta Neurol Scand. 2009 Oct;120(4):242-5. doi: 10.1111/j.1600-0404.2008.01147.x. Epub 2008 Dec 22.

PMID:
19154539
16.

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

Rudick RA, Cookfair DL, Simonian NA, Ransohoff RM, Richert JR, Jacobs LD, Herndon RM, Salazar AM, Fischer JS, Granger CV, Goodkin DE, Simon JH, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munchsauer FE, O'Reilly K, Priore RL, Whitham RH, et al.

J Neuroimmunol. 1999 Jan 1;93(1-2):8-14.

PMID:
10378864
17.

[Magnetic resonance findings in the brain of patients with multiple sclerosis without oligoclonal bands in the cerebrospinal fluid].

Mesaroc S, Drulović J, Lević Z, Perić V.

Srp Arh Celok Lek. 2003 Jan-Feb;131(1-2):31-5. Serbian.

18.

Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands.

Vrethem M, Kvarnström M, Stenstam J, Cassel P, Gustafsson M, Landtblom AM, Ernerudh J.

Mult Scler. 2012 May;18(5):669-73. doi: 10.1177/1352458511424903. Epub 2011 Sep 30.

PMID:
21965416
19.

Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosis.

Lin MW, Suan D, Lenton K, Henniker T, Burke T, Vucic S, Fulcher DA.

Pathology. 2012 Apr;44(3):248-50. doi: 10.1097/PAT.0b013e3283511a87.

PMID:
22406478
20.

Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.

Dobson R, Ramagopalan S, Davis A, Giovannoni G.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):909-14. doi: 10.1136/jnnp-2012-304695. Epub 2013 Feb 21. Review.

PMID:
23431079
Items per page

Supplemental Content

Write to the Help Desk